Three scientists -- Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) -- were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Cause of 5 deaths in Taoyuan fire determined, blaze source unclear
08/31/2025 09:17 PM - Society
Use of ultrasound in Chinese traditional medicine possible by year-end
08/31/2025 09:10 PM - Culture
CKS Memorial Hall holds concert on Taiwan's censored songs
08/31/2025 09:09 PM - Science & Tech
4th Taiwan Tech Summit in Silicon Valley to take place Sept. 20
08/31/2025 08:33 PM - Culture
VP Hsiao joins Washington Nationals' Taiwan Heritage Day celebrations
08/31/2025 07:14 PM